Angela E. Glenn

FDA investigator · also recorded as I. Angela E. Glenn, Rue Angela E. Glenn

Appears on 10 documents from 2016 to 2024, mostly at sites in India. Most often cites general requirements (21 CFR 211.160).

10
Documents on file
5.2
Observations per 483
2016
First seen
2024
Most recent

What they cite most

From 47 observations

Activity by year

2016: 1, 2017: 2, 2018: 1, 2019: 5, 2024: 1

Where

India 8 · China 2

Is Angela E. Glenn coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Taixing SynTheAll Pharmaceutical Co., LtdSep 27, 2024 · Taixing, China
483 Amphastar Nanjing PharmaceuticalsOct 11, 2019 · Nanjing, China
483 Sun Pharmaceutical Industries LimitedMar 29, 2019 · Dadra, India
483 CIPLA LIMITEDMar 20, 2019 · Pune, India
483 Dr. Reddy's Laboratories Ltd. No 41 Quthbullapur MandalFeb 8, 2019 · Bachupally, India
483 CIPLA LIMITEDJan 28, 2019 · Salcette, India
483 Sun Pharmaceutical Industries Ltd. Halol - Baroda HighwayAug 31, 2018 · Halol, India

About this profile

What does Angela E. Glenn inspect?

Angela E. Glenn appears on 10 documents on file covering 9 sites, mostly in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.22 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Angela E. Glenn is dated Sep 27, 2024.

FDA Investigator Angela E. Glenn: 483s & Inspections · FDA Intel